Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 5/2003

01-05-2003 | Physiological Note

Lactic acidosis

Author: Daniel De Backer

Published in: Intensive Care Medicine | Issue 5/2003

Login to get access

Excerpt

Hyperlactatemia is considered a hallmark of ongoing tissue hypoxia, but this is not always the case, and erroneous conclusions may sometimes be drawn that lead to unjustified therapeutic interventions. In this note we discuss the possible implications of hyperlactatemia …
Literature
1.
Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A (2000) Evolution of lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock. Crit Care Med 28:114–119CrossRef
2.
Stacpoole PW, Wright EC, Baumgartner TG, Bersin RM, Buchalter S, Curry SH, Duncan CA, Harman EM, Henderson GN, Jenkinson S (1992) A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med 327:1564–1569CrossRef
3.
Gore DC, Jahoor F, Hibbert JM, DeMaria EJ (1996) Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 224:97–102CrossRef
4.
Bellomo R, Kellum JA, Pinsky MR (1996) Transvisceral lactate fluxes during early endotoxemia. Chest 110:198–204CrossRef
5.
De Backer D, Creteur J, Zhang H, Norrenberg M, Vincent JL (1997) Lactate production by the lungs in acute lung injury. Am J Respir Crit Care Med 156:1099–1104CrossRef
6.
De Backer D, Creteur J, Silva E, Vincent JL (2001) The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis. Crit Care Med 29:256–261CrossRef
7.
Haji-Michael PG, Ladriere L, Sener A, Vincent JL, Malaisse WJ (1999) Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metabolism 48:779–785CrossRef
8.
Levraut J, Ciebiera JP, Chave S, Rabary O, Jambou P, Carles M, Grimaud D (1998) Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 157:1021–1026CrossRef
9.
Weil MH, Afifi AA (1970) Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation 41:989–1001CrossRef
10.
Rivers E, Nguyen B, Havstadt S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377CrossRef
Metadata
Title
Lactic acidosis
Author
Daniel De Backer
Publication date
01-05-2003
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 5/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-1746-7

Other articles of this Issue 5/2003

Intensive Care Medicine 5/2003 Go to the issue

On the Web only

Thoughts on intensive care: from morphine to Merlyn and Tolstoy to television

Announcements

May 2003

Original

Prophylactic N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria following major abdominal surgery. A prospective, randomised, double-blinded, placebo-controlled clinical trial

Original

Triaging patients to the ICU: a pilot study of factors influencing admission decisions and patient outcomes

Correspondence

Comment on "Terlipressin in chronic hyperdynamic endotoxic shock: is it safe?" by P. Asfar

Correspondence

Generalizability of randomized control trials